IFM Investors Pty Ltd Acquires 688 Shares of Humana Inc. (NYSE:HUM)

IFM Investors Pty Ltd increased its holdings in Humana Inc. (NYSE:HUMGet Rating) by 3.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,712 shares of the insurance provider’s stock after purchasing an additional 688 shares during the period. IFM Investors Pty Ltd’s holdings in Humana were worth $10,163,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. BlackRock Inc. boosted its holdings in Humana by 4.4% during the first quarter. BlackRock Inc. now owns 11,751,892 shares of the insurance provider’s stock valued at $5,114,071,000 after acquiring an additional 497,536 shares during the period. Vanguard Group Inc. boosted its holdings in Humana by 9.2% during the first quarter. Vanguard Group Inc. now owns 10,927,647 shares of the insurance provider’s stock valued at $4,755,384,000 after acquiring an additional 919,325 shares during the period. Wellington Management Group LLP boosted its holdings in Humana by 38.8% during the first quarter. Wellington Management Group LLP now owns 8,775,376 shares of the insurance provider’s stock valued at $3,818,781,000 after acquiring an additional 2,453,565 shares during the period. State Street Corp lifted its stake in shares of Humana by 0.3% in the fourth quarter. State Street Corp now owns 5,726,024 shares of the insurance provider’s stock valued at $2,660,025,000 after buying an additional 15,994 shares during the period. Finally, Capital Research Global Investors lifted its stake in shares of Humana by 7.6% in the first quarter. Capital Research Global Investors now owns 4,164,456 shares of the insurance provider’s stock valued at $1,812,264,000 after buying an additional 292,456 shares during the period. 93.50% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HUM has been the subject of several research reports. Credit Suisse Group set a $548.00 target price on shares of Humana in a research note on Tuesday, July 19th. Morgan Stanley upgraded shares of Humana from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $494.00 to $549.00 in a research note on Tuesday. StockNews.com cut shares of Humana from a “strong-buy” rating to a “buy” rating in a research note on Friday, July 29th. Truist Financial increased their target price on shares of Humana from $550.00 to $570.00 and gave the company a “hold” rating in a research note on Friday, September 16th. Finally, SVB Leerink increased their price target on shares of Humana from $535.00 to $540.00 and gave the stock an “outperform” rating in a research report on Thursday, July 28th. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, Humana presently has a consensus rating of “Moderate Buy” and an average target price of $519.28.

Humana Stock Performance

Shares of Humana stock opened at $493.91 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.53 and a quick ratio of 1.53. The firm has a market cap of $62.50 billion, a P/E ratio of 20.16, a P/E/G ratio of 1.43 and a beta of 0.77. The firm has a 50 day simple moving average of $487.67 and a 200 day simple moving average of $460.98. Humana Inc. has a fifty-two week low of $351.20 and a fifty-two week high of $514.98.

Humana (NYSE:HUMGet Rating) last issued its quarterly earnings results on Wednesday, July 27th. The insurance provider reported $8.67 earnings per share for the quarter, beating analysts’ consensus estimates of $7.67 by $1.00. Humana had a net margin of 3.52% and a return on equity of 18.42%. The business had revenue of $23.66 billion during the quarter, compared to analyst estimates of $23.44 billion. During the same quarter last year, the business posted $6.89 earnings per share. Humana’s revenue for the quarter was up 14.6% compared to the same quarter last year. Sell-side analysts predict that Humana Inc. will post 24.99 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be issued a $0.7875 dividend. This represents a $3.15 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 29th. Humana’s dividend payout ratio (DPR) is 12.86%.

Insider Activity

In other news, insider Joseph C. Ventura sold 1,226 shares of the business’s stock in a transaction on Tuesday, September 20th. The shares were sold at an average price of $506.78, for a total value of $621,312.28. Following the completion of the transaction, the insider now owns 3,930 shares of the company’s stock, valued at approximately $1,991,645.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.39% of the stock is owned by company insiders.

Humana Profile

(Get Rating)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMGet Rating).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.